IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

1. Recent Advances in Non-Invasive Blood Markers for Intraductal Papillary Mucinous Neoplasm Grading.Oncology research · 2026
   Review
2. Single-cell RNA sequencing reveals the adverse role of cDC3s in the response of ulcerative colitis patients to anti-TNF-α therapy.Journal of translational medicine · 2025
   Article
3. Granzyme B and melittin in cancer immunotherapy: molecular mechanisms and therapeutic perspectives in head and neck cancers.Frontiers in immunology · 2025
   Review
4. Emerging Canonical and Non-Canonical Roles of Granzyme B in Health and Disease.Cancers · 2022
   Review
5. Regulation of the Migration of Distinct Dendritic Cell Subsets.Frontiers in cell and developmental biology · 2021
   Review
6. Basal-like breast cancer with low TGFβ and high TNFα pathway activity is rich in activated memory CD4 T cells and has a good prognosis.International journal of biological sciences · 2021
   Article
7. Immunological evaluation of invasive Lactobacillus plantarum co-expressing EtMIC2 and chicken interleukin-18 against Eimeria tenella.Parasitology research · 2020
   Article
8. Quantitative evaluation of tumor-specific T cells in tumors and lymphoid tissues.Methods in enzymology · 2020
   Article
9. Mesenchymal stem cells expressing interleukin-18 inhibit breast cancer in a mouse model.Oncology letters · 2018
   Article
10. Tumor immunotherapy: New aspects of natural killer cells.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2018
    Article
11. Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents.Nature protocols · 2018
    Article
12. Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development.Frontiers in immunology · 2017
    Review
13. The Role of Chemokines in Promoting Colorectal Cancer Invasion/Metastasis.International journal of molecular sciences · 2016
    Review
14. Overexpression of interleukin-18 protein reduces viability and induces apoptosis of tongue squamous cell carcinoma cells by activation of glycogen synthase kinase-3β signaling.Oncology reports · 2015
    Article
15. Dendritic cell-based vaccine efficacy: aiming for hot spots.Frontiers in immunology · 2015
    Review
16. The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
17. Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.Oncoimmunology · 2014
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 2 institutions in 1 country.

Funding

Abstract

Indexed as